Patents by Inventor Toshiaki Nishihata

Toshiaki Nishihata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4699776
    Abstract: A rectally administered unit dosage form comprising a therapeutically effective amount of an analgesic , an antipyretic or an anti-inflammatory agent capable of being absorbed into the bloodstream from a rectal compartment and an adjuvant, said adjuvant comprising lecithin present in said dosage form in a sufficient amount to be effective in enhancing and prolonging the absorption rate of said analgesic, antipyretic or anti-inflammatory agent from the rectal compartment into the bloodstream, in conjunction with a nontoxic, pharmaceutically acceptable carrier and the methods of using said unit dosage form.
    Type: Grant
    Filed: June 28, 1985
    Date of Patent: October 13, 1987
    Assignee: R. P. Scherer Corporation
    Inventors: Toshiaki Nishihata, Akira Kamada, Hisayo Wada
  • Patent number: 4470980
    Abstract: A method and drug form are provided for increasing the oral absorption of .beta.-lactam antibiotics such as the penicillins, cephalosporins and related chemical species by the oral administration of said .beta.-lactam antibiotics in a suitable pharmaceutically accepted excipient to which has been added a hydroxy aryl or hydroxy aralkyl acid or salt, amide or ester thereof. The hydroxyaryl or hydroxyaralkyl acid or salt, amide or ester thereof is present in the drug form in quantities sufficient to be effective in enhancing the rate of oral absorption of the .beta.-lactam antibiotic.
    Type: Grant
    Filed: June 25, 1981
    Date of Patent: September 11, 1984
    Assignee: INTERx Research Corp.
    Inventors: Takeru Higuchi, Toshiaki Nishihata
  • Patent number: 4464363
    Abstract: A method and drug form for enhancing the rate of absorption of a rectally administered drug from the rectal compartment into the blood stream of a warm blooded animal. The method includes the steps of preparing a drug form capable of being rectally administered. The drug form comprises a therapeutically effective unit dosage amount of a selected drug of the type which is capable of being absorbed into the blood stream from the rectal compartment and hydroxy aryl or hydroxy aralkyl acids or salts, amides or esters thereof, the hydroxy aryl or hydroxy aralkyl acids or salts, amides or esters thereof being present in the drug form in a sufficient amount to be effective in enhancing the drug absorption rate, when rectally administering the drug form to warm blooded animals.
    Type: Grant
    Filed: June 25, 1981
    Date of Patent: August 7, 1984
    Assignee: Merck & Co., Inc.
    Inventors: Takeru Higuchi, Toshiaki Nishihata, Howard J. Rytting
  • Patent number: 4462991
    Abstract: A method and drug form are provided for increasing the oral absorption of polar bioactive agents such as polypeptides by the oral administration of said polar bioactive agents in a suitable pharmaceutically accepted excipient to which has been added a hydroxyaromatic acid or salt as an adjuvant thereof. The adjuvant is present in the drug form in quantities sufficient to be effective in enhancing the rate of oral absorption of the polar bioactive agents.
    Type: Grant
    Filed: June 11, 1982
    Date of Patent: July 31, 1984
    Assignee: INTERx Research Corp.
    Inventors: Takeru Higuchi, Toshiaki Nishihata
  • Patent number: 4459295
    Abstract: A method and drug form are provided for increasing the oral absorption of glycosidic and related antibiotics such as macrolide, aminoglycoside, lincomycin and anthracycline antibiotics and related chemical species by the oral administration of said glycosidic and related antibiotics in a suitable pharmaceutically accepted excipient to which has been added a hydroxyaryl or hydroxyaralkyl acid or salt thereof. The hydroxyaryl or hydroxyaralkyl acid or salt thereof is present in the drug form in quantities sufficient to be effective in enhancing the rate of oral absorption of glycosidic and related antibiotic.
    Type: Grant
    Filed: June 11, 1982
    Date of Patent: July 10, 1984
    Assignee: INTERx Research Corporation
    Inventors: Takeru Higuchi, Toshiaki Nishihata
  • Patent number: 4406896
    Abstract: A method and drug form for enhancing the rate of absorption of a rectally administered drug from the rectal compartment into the blood stream of a warm blooded animal. The method includes the steps of preparing a .beta.-lactam drug form capable of being rectally administered. The drug form comprises a therapeutically effective unit dosage amount of a selected drug of the type which is capable of being absorbed into the blood stream from the rectal compartment and hydroxy aryl or hydroxy aralkyl acids or salts, amides or esters thereof, the hydroxy aryl or hydroxy aralkyl acids or salts, amides or esters thereof being present in the drug form in a sufficient amount to be effective in enhancing the drug absorption rate, when rectally administering the drug form to warm blooded animals.
    Type: Grant
    Filed: June 25, 1981
    Date of Patent: September 27, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Takeru Higuchi, Toshiaki Nishihata, Howard J. Rytting